Acadian Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $9K | Buy |
|
|||||
|
2024
Q4 | $55K | Buy |
|
|||||
|
2024
Q3 | $113K | Buy |
|
|||||
|
2024
Q2 | $178K | Buy |
|
|||||
|
2024
Q1 | $91K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $34K | Sell |
|
|||||
|
2022
Q4 | $62K | Sell |
|
|||||
|
2022
Q3 | $156K | Buy |
|
|||||
|
2022
Q2 | $132K | Buy |
|
|||||
|
2022
Q1 | $97K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.93M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $126K | Buy |
|
|||||
|
2020
Q3 | $41K | Sell |
|
|||||
|
2020
Q2 | $598K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $182K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $99K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $66K | Sell |
|
|||||
|
2018
Q2 | $288K | Buy |
|
|||||
|
2018
Q1 | $5K | Buy |
|